Diabetes & Endocrinology News

• Study Suggests Inappropriate Use of Thyroid Ultrasounds Of all new, dedicated thyroid ultrasounds performed at a single tertiary care center, only a quarter identified biopsy-recommended nodules, whereas nearly 40% did not find any nodules.
  Medscape Medical News, December 18, 2023
• Novo Owner Commits $265 Million Of Wegovy Windfall to Respiratory Diseases The Novo Nordisk Foundation, which controls drug maker Novo Nordisk, said on Monday it would commit up to 1.8 billion Danish crowns ($265 million) to setting up an...
  Reuters Health Information, December 18, 2023
• Exclusive-IndiaMART Is Working With Novo Nordisk to Halt Illegal Wegovy Sales -source Indian online marketplace IndiaMART has been removing unauthorized listings of Novo Nordisk's blockbuster weight-loss drug Wegovy after holding talks with the Danish...
  Reuters Health Information, December 17, 2023
• What Causes Obesity? More Science Points to the Brain In the battle against obesity, one crucial organ has been long overlooked.
  WebMD Health News, December 15, 2023
• Compounders: Don't Listen to Bad Press on GLP-1s The compounding industry is trying to quell misconceptions about its GLP-1 products, which prescribers can order while branded versions of the drugs are in short supply.
  Medscape Medical News, December 15, 2023
• 'We Will Rock You' Into Real-time Diabetes Control Rock music could offer patients with type 1 diabetes the means to stimulate insulin release and achieve real-time diabetes control via adapted pancreatic cells and speakers, suggests a novel study.
  Medscape Medical News, December 15, 2023
• Alcohol and CV Risk: Both Beneficial and Harmful Effects? Some research has suggested that moderate alcohol consumption can benefit the heart, but new findings suggest that the picture is even more complicated than previously thought.
  Medscape Medical News, December 14, 2023
• Navigating the Semaglutide Shortage Grappling with a shortage of obesity drugs, doctors find themselves at the forefront of strategic decision-making to ensure optimal patient care.
  Medscape Medical News, December 14, 2023
• GLP-1 RAs for CVD: Are Cardiologists Ready? The SELECT trial catapulted GLP-1 RAs into the forefront of CVD prevention, but cardiologists are making their own decisions about whether and how they might integrate these agents into practice.
  Medscape Medical News, December 14, 2023
• What if a Single GLP-1 Shot Could Last for Months? New hydrogel technology could reduce GLP-1 injections from daily or weekly to three times a year.
  Medscape Medical News, December 14, 2023
• AI-Aided Stethoscope Beats PCP in Detecting Valvular HD A stethoscope that uses AI is more sensitive to detecting signs of valvular heart disease than a standard stethoscope is in the hands of a primary care physician, a new study shows.
  Medscape Medical News, December 13, 2023
• US Task Force Takes on Rising BMIs Among Kids The US Preventive Services Task Force issued a draft recommendation statement outlining the interventions that should be taken when a child or teen has a high body mass index.
  WebMD Health News, December 13, 2023
• U.S. Healthcare Spending Rises to $4.5 Trillion in 2022 Healthcare spending in the United States rose 4.1% in 2022 to $4.5 trillion, federal data showed on Wednesday, a rate that officials said indicated a return to pre-pandemic...
  Reuters Health Information, December 13, 2023
• US Employers Hire Virtual Providers as Weight-loss Drug Gatekeepers U.S. employers facing surging costs from paying for Novo Nordisk’s Wegovy and similar obesity drugs are hiring virtual healthcare providers like Teladoc to implement...
  Reuters Health Information, December 13, 2023
• Kids Who Are Overweight at Risk for Chronic Kidney Disease An increased risk for early CKD is observed even among adolescents with high-normal BMI and without diabetes.
  Medscape Medical News, December 12, 2023
• Stem Cell Therapy Implant Shows Promise for Type 1 Diabetes An experimental device containing millions of stem cells significantly reduced the need for insulin shots among people with type 1 diabetes.
  WebMD Health News, December 12, 2023
• US Panel Recommends Children With Obesity Start Counseling From Age 6 Children with obesity should receive intensive counseling to promote healthy diet and exercise habits starting at age 6, according to a draft recommendation issued by a...
  Reuters Health Information, December 12, 2023
• New NIST Standard Will Improve Diagnosis of Kidney Disease The US National Institute of Standards and Technology has developed the first human urine standard with accurate measurements of albumin.
  Medscape Medical News, December 12, 2023
• ADA Issues New Screening, Obesity Management Recommendations Updates to the American Diabetes Association's Standards of Care for 2024 include multiple new screening recommendations, as well as new obesity management guidance and other revisions.
  Medscape Medical News, December 12, 2023
• What Is the Link Between Cellphones and Male Fertility? A recent Swiss study, despite having a better methodology than previous research, can do little more than fuel hypotheses.
  Medscape Medical News, December 12, 2023
• AANEM 2023 Novel Myasthenia Gravis Therapies Bring Opportunities New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.
  MDedge News, November 27, 2023
• Novo to Launch Wegovy in Asia With February Roll-Out in Japan Novo Nordisk will launch its hugely popular anti-obesity drug in Japan on February 22, its first launch in Asia, even as it struggles to keep up with demand in existing markets.
  Reuters Health Information, November 23, 2023
• Novo Invests $2.3 Billion in France for Obesity Drug Production Novo Nordisk has announced a $2.3 billion investment to boost production of its wildly popular weight-loss and diabetes drugs at a site in Chartres, France.
  Reuters Health Information, November 23, 2023
• Cyberattacks Challenge Canadian Health Information Systems A new analysis recommends a four-stage plan for physicians and health systems to improve their cybersecurity practices.
  Medscape Medical News, November 27, 2023
• Metoclopramide Nasal Spray Eases Gastroparesis in Women A nasal spray formulation of metoclopramide was well tolerated and reduced symptoms of diabetic gastroparesis in women with moderate to severe baseline symptoms in a phase 3 study
  Medscape Medical News, November 27, 2023
• Novo Rations Ozempic Starter Kits Novo Nordisk will ration starter kits of Ozempic in Europe and reduce supplies of another diabetes drug, Victoza, to prioritize producing Ozempic.
  Reuters Health Information, November 21, 2023
• Medtronic Shrugs Off Concerns Over Newer Weight-Loss Drugs Medtronic raised its annual earnings forecast on Tuesday as strong sales in its surgical and diabetes units allayed concerns about the impact of new diabetes and weight-loss drugs on long-term growth.
  Reuters Health Information, November 21, 2023
• WCN 2023 A Role for Neurologists in Diabetic Peripheral Neuropathy The rise in diabetic neuropathy over the last few decades has paralleled the obesity and related diabetes pandemics, one expert says, and neurologists have a role to play in controlling it.
  Medscape Medical News, November 21, 2023
• AHA 2023 Promising First Results With DNA Editing to Lower LDL The first-in-human HEART-1 trial of in vivo DNA editing called VERVE-101, shows reductions in LDL and PCSK9 protein in patients with familial hypercholesterolemia.
  MDedge News, November 21, 2023
• Study Confirms Link Between Red Meat and Diabetes Risk The findings support the current dietary recommendations of limiting consumption of red meat and highlight the importance of alternative sources of protein, according to the researchers.
  Medscape Medical News, November 21, 2023
• Placental Cell Disruption Tied to Adult Depression, CVD Disruption of placental Hofbauer cell function caused by prenatal infection or preterm birth may increase the risk for depression and cardiovascular disease in adulthood.
  Medscape Medical News, November 21, 2023
• How Should We Screen Transgender Patients for Cancer? The risk of cancer is not eliminated with gender transition, and the methods of screening should be adapted, say experts.
  Medscape Medical News, November 21, 2023
• Differences in Twins Suggest Obesity Veers From Genetics When twins have significant differences in body mass index, the higher BMI more commonly veers from the genetically predicted BMI.
  Medscape Medical News, November 21, 2023
• Choosing the Right Approach to Cancer and Menopause Symptoms Hormone replacement therapy may be considered to lessen these symptoms, but only in certain conditions, said a gynecologist.
  Medscape Medical News, November 21, 2023
• Circadian Calorie-Burning Cycles Altered in Obesity Among people with obesity, the lowest point of energy expenditure is not during sleeping hours, as seen in those without obesity.
  Medscape Medical News, November 21, 2023
• PREVENT: AHA's New Risk Calculator Incorporates CKM Health The new cardiovascular disease risk equations start at age 30, include measures of kidney and metabolic health, add heart failure, and remove race from the equations.
  Medscape Medical News, November 20, 2023
• Already-Available Drug Could Help Treat Type 1 Diabetes The ornithine decarboxylase inhibitor α-difluoromethylornithine, used to treat African sleeping sickness and unwanted hair growth, may also protect β cells of people with new-onset type 1 diabetes.
  Medscape Medical News, November 20, 2023
• Alert FDA OKs Symplicity Renal Denervation System for Hypertension After a mixed FDA panel review in August, the agency has approved Medtronic's Symplicity Spyral renal denervation system for treatment of hypertension.
  Medscape Medical News, November 20, 2023
• What’s Behind the Scramble for Semaglutide? Demand for a diabetes medicine called Ozempic is soaring as people take it to shed pounds, leading to shortages in countries including Britain, Germany, Belgium and the United States.
  Reuters Health Information, November 18, 2023
• Manufacturer Lonza Says It Will Not Fill Obesity Drug Syringes Lonza's chairman has ruled out plans to use its capacity to fill syringes and provide final production steps for new obesity drugs even as rivals scramble for a share of the booming weight-loss market.
  Reuters Health Information, November 17, 2023